44F-41043-80673 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-23
Registered in v-safe
2020-12-23
Dose 1 — Pfizer-BioNTech
2020-12-23
Health check-in — day 0, dose 1
Feeling: Good · None

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-01
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-08
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-11
Dose 2 — Pfizer-BioNTech
2021-01-27
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-08
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-10-01
Dose 3 — Pfizer-BioNTech
2021-10-04
Survey response — days 1–6 daily, dose 3
MedDRA: Oedema peripheral — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Swollen axillae on side of injection site

MedDRA releases: 2024-11 · check-in free text available
2021-10-05
Survey response — days 1–6 daily, dose 3
MedDRA: Oedema peripheral — Feeling: Good

Free text: Swelling in armpit near injection site

MedDRA releases: 2024-11 · check-in free text available
2021-10-18
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-12-31
Survey response — 3 months, dose 3
MedDRA: Mastitis, Staphylococcal infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Mastitis with MRSA

MedDRA releases: 2024-11 · check-in free text available
2021-12-31
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-01-03
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-23	Pfizer-BioNTech
2	2021-01-11	Pfizer-BioNTech
3	2021-10-01	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-12-31	Unsuccessful

Free text

Release 10 — days 1–6 daily, dose 3

2021-10-04

Systemic reaction (other): Swollen axillae on side of injection site

2021-10-05

Systemic reaction (other): Swelling in armpit near injection site

Release 10 — 3 months, dose 3

2021-12-31

Symptoms: Mastitis with MRSA

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Mastitis	·	·	✓
SD	Staphylococcal infection	·	·	✓
SRO	Oedema peripheral	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release